| Company Name: |
BOC Sciences |
| Tel: |
+1-631-485-4226 |
| Email: |
inquiry@bocsci.com |
|
| | N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)aMino]dodecanoyl]-D-glucosyl-1-1'-sphingosine Basic information |
| Product Name: | N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)aMino]dodecanoyl]-D-glucosyl-1-1'-sphingosine | | Synonyms: | N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)aMino]dodecanoyl]-D-glucosyl-1-1'-sphingosine;N-[12-[(7-NITRO-2-1,3-BENZOXADIAZOL-4-YL)AMINO]DODECANOYL]-D-GLUCOSYL-1-1'-SPHINGOSINE;C12-NBD GLUCOSYL CERAMIDE;Dodecanamide, N-[(1S,2R,3E)-1-[(β-D-glucopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]-12-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-;N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-glucosyl-β1-1'-sphingosine | | CAS: | 474943-01-6 | | MF: | C42H71N5O11 | | MW: | 822.04 | | EINECS: | | | Product Categories: | | | Mol File: | 474943-01-6.mol | ![N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)aMino]dodecanoyl]-D-glucosyl-1-1'-sphingosine Structure](CAS/20180808/GIF/474943-01-6.gif) |
| | N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)aMino]dodecanoyl]-D-glucosyl-1-1'-sphingosine Chemical Properties |
| density | 1.221±0.10 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | storage temp. | -20°C | | form | liquid | | pka | 12.890±0.70(predicted) |
| WGK Germany | WGK 3 | | Hazard Classifications | Acute Tox. 3 Inhalation Acute Tox. 4 Oral Carc. 2 Eye Irrit. 2 Repr. 2 Skin Irrit. 2 STOT RE 1 STOT SE 3 |
| | N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)aMino]dodecanoyl]-D-glucosyl-1-1'-sphingosine Usage And Synthesis |
| Uses | C12-NBD Glucosyl Ceramide is suitable for liposome preparation. | | Biological Activity | Glucosyl ceramide (GlcCer) is produced by GlcCer synthase from ceramide in the cytosolic membranes of Golgi. In the luminal Golgi membrane, GlcCer participates in the generation of glycosphingolipids. |
| | N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)aMino]dodecanoyl]-D-glucosyl-1-1'-sphingosine Preparation Products And Raw materials |
|